101 related articles for article (PubMed ID: 3150878)
1. A comparison of the efficacy and side effects of various regimens of praziquantel for the treatment of schistosomiasis.
el Masry NA; Bassily S; Farid Z
Trans R Soc Trop Med Hyg; 1988; 82(5):719-20. PubMed ID: 3150878
[No Abstract] [Full Text] [Related]
2. [Effectiveness and tolerance of praziquantel in schistosomiasis].
Groning E; Bakathir H; Salem A; Albert L; Fernández R
Rev Cubana Med Trop; 1985; 37(2):215-9. PubMed ID: 3938555
[No Abstract] [Full Text] [Related]
3. Dosage trial of a combination of oxamniquine and praziquantel in the treatment of schistosomiasis in Zimbabwean schoolchildren.
Creasey AM; Taylor P; Thomas JE
Cent Afr J Med; 1986 Jul; 32(7):165-7. PubMed ID: 3107836
[No Abstract] [Full Text] [Related]
4. The efficacy of praziquantel in Egyptian schistosomiasis.
Ismail MM; Bruce JI; Attia MM; el-Ridi AM; Shabayek HA; Salama MM
J Egypt Soc Parasitol; 1986 Jun; 16(1):259-67. PubMed ID: 3088142
[No Abstract] [Full Text] [Related]
5. Evaluation of praziquantel efficiency in the treatment of schistosomiasis.
Khalil HM; el-Hawey AM; Abdel Baki MH; el-Hadi HM; Sharara MO
J Egypt Soc Parasitol; 1986 Dec; 16(2):403-12. PubMed ID: 3097166
[No Abstract] [Full Text] [Related]
6. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
[TBL] [Abstract][Full Text] [Related]
7. Praziquantel in treatment of S. mansoni and S. haematobium infections.
Ahmed TH; Ali AA; Bassiouni GA; Omer SH; Shalaby MA
J Egypt Soc Parasitol; 1988 Jun; 18(1):313-24. PubMed ID: 3131447
[No Abstract] [Full Text] [Related]
8. Blood picture and liver function tests before and after praziquantel therapy of Egyptian bilharzial patients.
Ata AA; el-Raziky EH; el-Ridi AM; Ismail MM; Attia MM; el-Gamal RL; el-Khashab M
J Egypt Soc Parasitol; 1986 Jun; 16(1):277-85. PubMed ID: 3088144
[No Abstract] [Full Text] [Related]
9. [Therapeutic management of schistosomiasis as an imported disease in The Netherlands].
Stuiver PC; Smith SJ; Polderman AM
Ned Tijdschr Geneeskd; 1989 Jan; 133(4):153-4. PubMed ID: 2493591
[No Abstract] [Full Text] [Related]
10. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium.
Taylor P; Murare HM; Manomano K
J Trop Med Hyg; 1988 Feb; 91(1):13-7. PubMed ID: 3126306
[TBL] [Abstract][Full Text] [Related]
12. Enzyme linked immunosorbent assay for the evaluation of praziquantel therapy in different groups of bilharzial patients.
Ismail MM; Ata AA; el-Raziky EH; el-Ridi AM; Attia MM; el-Gamal RL; el-Khashab M
J Egypt Soc Parasitol; 1986 Jun; 16(1):269-76. PubMed ID: 3088143
[No Abstract] [Full Text] [Related]
13. Seasonality as a determinant of the efficacy of praziquantel in population-based chemotherapy: lessons from the practice.
Abu-Elyazeed RR; Mansour NS; Youssef FG; Boghdadi AM; el Khoby TA; Hassanein YA; el Gamal RR
J Egypt Soc Parasitol; 1998 Apr; 28(1):1-7. PubMed ID: 9617037
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
Barda B; Coulibaly JT; Puchkov M; Huwyler J; Hattendorf J; Keiser J
PLoS Negl Trop Dis; 2016 Sep; 10(9):e0005008. PubMed ID: 27636542
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of praziquantel as an antihelmintic agent in the treatment of bilharziasis].
Doehring E; Ehrich JH
Monatsschr Kinderheilkd; 1986 May; 134(5):282-4. PubMed ID: 3088435
[TBL] [Abstract][Full Text] [Related]
17. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
[TBL] [Abstract][Full Text] [Related]
18. Schistosomiasis update.
Gilles HM
Int J Dermatol; 1988; 27(6):400-1. PubMed ID: 3147951
[No Abstract] [Full Text] [Related]
19. The status of schistosomiasis before and after treatment among school pupils in a village in the Nile Delta, Egypt.
Ismail MM; Bruce JI; Attia M; Husein MH; Sabah AA; Tayel SE
J Egypt Soc Parasitol; 1988 Jun; 18(1):287-96. PubMed ID: 3131446
[No Abstract] [Full Text] [Related]
20. Side effects of praziquantel in bilharzial children on a field level.
el-Hawey AM; Massoud AM; el-Rakieby A; Rozeik MS; Nassar MO
J Egypt Soc Parasitol; 1990 Dec; 20(2):599-605. PubMed ID: 2121846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
